What are the clinical outcomes of Nusinersen treatment?
Clinical trials and real-world studies have demonstrated that Nusinersen can significantly improve motor function and slow disease progression in patients with SMA. Infants treated with Nusinersen have shown improvements in motor milestones such as sitting, crawling, and walking. The treatment has also been associated with prolonged survival and reduced need for ventilatory support in severe cases.
